Filing Details
- Accession Number:
- 0001127602-13-020619
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-18 10:49:39
- Reporting Period:
- 2013-06-14
- Filing Date:
- 2013-06-18
- Accepted Time:
- 2013-06-18 10:49:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242215 | C Joseph Papa | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | President And Ceo | Yes | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-14 | 10,000 | $35.85 | 110,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-14 | 8,095 | $118.31 | 101,905 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-06-14 | 1,905 | $118.75 | 100,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option Right to Buy | Acquisiton | 2013-06-14 | 10,000 | $0.00 | 10,000 | $35.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 43,963 | 2018-08-25 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 8, 2012. This 10b5-1 sales plan will expire on the close of business November 8, 2013.
- The price in column 4 is a weighted average. The prices actually received ranged from $117.64 to $118.64. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $118.65 to $118.89. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Exercisable in 3 equal annual installments beginning 8/25/09.
Billionaire Hedge Funds
